Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Current Neuropharmacology
|
January 9, 2026
A Case-Control Study On Corpus Callosum Volume and Clinical Correlates in Treatment-Resistant and Responsive Schizophrenia Patients: Addressing MRI Analysis within Single-Subject and a Novel Artificial Intelligence Paradigm
Marta Matrone, Andrea Romano, Georgios D Kotzalidis, et al.
Journal of Addictive Diseases
|
February 15, 2021
Developmental trajectories in psychiatric disorders: does substance/alcohol use moderate the effects of affective temperaments as moderators of age at onset? A study in post-acute, hospitalized patients with psychotic or DSM-5 bipolar or major depressive disorders
Filippo Perrini, Marta Matrone, Andrea de Bartolomeis, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
December 9, 2021
Treatment-resistant schizophrenia: Addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients
Marta Matrone, Georgios D Kotzalidis, Andrea Romano, et al.
Pharmacotherapy
|
March 19, 2013
Intramuscular aripiprazole in the acute management of psychomotor agitation
Sergio De Filippis, Ilaria Cuomo, Luana Lionetto, et al.
Journal of Affective Disorders
|
September 5, 2024
Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study
Giacomo d'Andrea, Andrea Miuli, Mauro Pettorruso, et al.
International Journal of Molecular Sciences
|
February 13, 2025
Optimising Aripiprazole Long-Acting Injectable: A Comparative Study of One- and Two-Injection Start Regimens in Schizophrenia with and Without Substance Use Disorders and Relationship to Early Serum Levels
Giada Trovini, Ginevra Lombardozzi, Georgios D Kotzalidis, et al.
Addictive Behaviors
|
April 19, 2016
Use of benzylglycinamide by a HIV-seropositive polysubstance user: The changing pattern of novel psychoactive substance use among youths
Matteo Caloro, Giuseppa Calabrò, Georgios D Kotzalidis, et al.
Journal of Affective Disorders
|
October 29, 2025
Retrospective multicenter cohort study of slow titration of vortioxetine to mitigate early nausea in major depression
Andrea Fagiolini, Andrea Aguglia, Emi Bondi, et al.
Annals of General Psychiatry
|
November 6, 2024
Treatment satisfaction and effectiveness of Lurasidone on quality of life and functioning in adult patients with schizophrenia in the real-world Italian clinical practice: a prospective 3-month observational study
Sergio De Filippis, Antonio Vita, Alessandro Cuomo, et al.
Annals of General Psychiatry
|
September 29, 2022
Treatment persistence with aripiprazole once monthly: a 4-year follow-up
Andrea Fagiolini, Eugenio Aguglia, Andrea Ballerini, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Current Neuropharmacology
|
January 9, 2026
A Case-Control Study On Corpus Callosum Volume and Clinical Correlates in Treatment-Resistant and Responsive Schizophrenia Patients: Addressing MRI Analysis within Single-Subject and a Novel Artificial Intelligence Paradigm
Marta Matrone, Andrea Romano, Georgios D Kotzalidis, et al.
Journal of Addictive Diseases
|
February 15, 2021
Developmental trajectories in psychiatric disorders: does substance/alcohol use moderate the effects of affective temperaments as moderators of age at onset? A study in post-acute, hospitalized patients with psychotic or DSM-5 bipolar or major depressive disorders
Filippo Perrini, Marta Matrone, Andrea de Bartolomeis, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
December 9, 2021
Treatment-resistant schizophrenia: Addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients
Marta Matrone, Georgios D Kotzalidis, Andrea Romano, et al.
Pharmacotherapy
|
March 19, 2013
Intramuscular aripiprazole in the acute management of psychomotor agitation
Sergio De Filippis, Ilaria Cuomo, Luana Lionetto, et al.
Journal of Affective Disorders
|
September 5, 2024
Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study
Giacomo d'Andrea, Andrea Miuli, Mauro Pettorruso, et al.
International Journal of Molecular Sciences
|
February 13, 2025
Optimising Aripiprazole Long-Acting Injectable: A Comparative Study of One- and Two-Injection Start Regimens in Schizophrenia with and Without Substance Use Disorders and Relationship to Early Serum Levels
Giada Trovini, Ginevra Lombardozzi, Georgios D Kotzalidis, et al.
Addictive Behaviors
|
April 19, 2016
Use of benzylglycinamide by a HIV-seropositive polysubstance user: The changing pattern of novel psychoactive substance use among youths
Matteo Caloro, Giuseppa Calabrò, Georgios D Kotzalidis, et al.
Journal of Affective Disorders
|
October 29, 2025
Retrospective multicenter cohort study of slow titration of vortioxetine to mitigate early nausea in major depression
Andrea Fagiolini, Andrea Aguglia, Emi Bondi, et al.
Annals of General Psychiatry
|
November 6, 2024
Treatment satisfaction and effectiveness of Lurasidone on quality of life and functioning in adult patients with schizophrenia in the real-world Italian clinical practice: a prospective 3-month observational study
Sergio De Filippis, Antonio Vita, Alessandro Cuomo, et al.
Annals of General Psychiatry
|
September 29, 2022
Treatment persistence with aripiprazole once monthly: a 4-year follow-up
Andrea Fagiolini, Eugenio Aguglia, Andrea Ballerini, et al.
Page
of 7